A

AN2 Therapeutics
D

ANTX

5.80000
USD
0.02
(0.35%)
مغلق
حجم التداول
3,591
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
218,870,175
المقالات
المزيد

العنوان: AN2 Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.